Q301--Intent to Sole Source Specialized laboratory medical testing services

The Department of Veterans Affairs, Veterans Integrated Service Network 21, issued a notice of intent to sole source a firm fixed price contract for specialized laboratory medical testing services to Mayo Collaborative Services, Inc., with responses due by July 24, 2026 at 10:00 AM PST. The VA believes Mayo is the sole authorized provider capable of performing the required services and that no other third parties hold authorization to deliver them.

The contract covers a base year (October 1, 2026 through September 30, 2027) plus four one-year option periods through September 30, 2030. Services encompass specialized neurological and immunological laboratory testing including CNS demyelinating disease evaluation, serum CRMP-5 neuronal IgG titer, serum GAD65 antibody assay, spinal fluid glycine receptor alpha1 IgG cell binding assay, serum lactate dehydrogenase (LDH), body fluid myelin oligodendrocyte glycoprotein (MOG-IgG-1) FACS titer assay, and neuromyelitis optica/aquaporin-4 FACS IgG assay titer testing. Testing will be performed at the contractor's facility for VA Palo Alto Health Care System, with results reported via Laboratory Information System interface or fax. Staff must maintain current CLIA certifications and state licenses; work must occur under supervision of qualified clinical or anatomic pathologists and state-licensed or nationally certified medical technologists.

Contractors believing they possess capability and authorization to perform these services must submit capability documentation and an authorization letter from Mayo Collaborative Services, Inc., to Angela Gerlitzki at angela.gerlitzki1@va.gov by the deadline. The applicable NAICS code is 621511 (Medical Laboratories) with a size standard of $41.5 million. This notice is not a competitive request for quotes; the government reserves discretion to compete the procurement based on responses received.